CIBC Private Wealth Group’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $3.22M | Sell |
13,368
-903
| -6% | -$231K | 0.01% | 495 |
|
|
2025
Q3 | $3.91M | Buy |
14,271
+632
| +5% | +$173K | 0.01% | 468 |
|
|
2025
Q2 | $3.52M | Sell |
13,639
-164
| -1% | -$39.1K | 0.01% | 475 |
|
|
2025
Q1 | $2.82M | Sell |
13,803
-174
| -1% | -$40.6K | 0.01% | 486 |
|
|
2024
Q4 | $3.3M | Sell |
13,977
-56
| -0.4% | -$13.5K | 0.01% | 487 |
|
|
2024
Q3 | $3.43M | Sell |
14,033
-2,453
| -15% | -$548K | 0.01% | 489 |
|
|
2024
Q2 | $3.18M | Buy |
16,486
+68
| +0.4% | +$13.8K | 0.01% | 471 |
|
|
2024
Q1 | $3.11M | Sell |
16,418
-1,331
| -7% | -$244K | 0.01% | 473 |
|
|
2023
Q4 | $3.05M | Sell |
17,749
-214,727
| -92% | -$33M | 0.01% | 450 |
|
|
2023
Q3 | $34.4M | Sell |
232,476
-1,756
| -0.7% | -$318K | 0.08% | 199 |
|
|
2023
Q2 | $51.2M | Buy |
234,232
+86,352
| +58% | +$19.2M | 0.11% | 158 |
|
|
2023
Q1 | $16.3M | Sell |
147,880
-1,378
| -0.9% | -$299K | 0.04% | 271 |
|
|
2022
Q4 | $29.9M | Buy |
149,258
+1,665
| +1% | +$366K | 0.1% | 136 |
|
|
2022
Q3 | $32.2M | Buy |
147,593
+18,025
| +14% | +$4.1M | 0.09% | 170 |
|
|
2022
Q2 | $27.2M | Sell |
129,568
-2,791
| -2% | -$594K | 0.07% | 197 |
|
|
2022
Q1 | $32.1M | Buy |
132,359
+2,285
| +2% | +$553K | 0.07% | 194 |
|
|
2021
Q4 | $33.9M | Buy |
130,074
+168
| +0.1% | +$43.6K | 0.07% | 193 |
|
|
2021
Q3 | $34.2M | Sell |
129,906
-2,041
| -2% | -$558K | 0.08% | 179 |
|
|
2021
Q2 | $32.5M | Sell |
131,947
-1,807
| -1% | -$380K | 0.07% | 188 |
|
|
2021
Q1 | $25.9M | Sell |
133,754
-5,380
| -4% | -$1.08M | 0.07% | 214 |
|
|
2020
Q4 | $29.6M | Sell |
139,134
-2,443
| -2% | -$487K | 0.08% | 185 |
|
|
2020
Q3 | $24.3M | Buy |
141,577
+1,546
| +1% | +$285K | 0.07% | 180 |
|
|
2020
Q2 | $26.9M | Buy |
140,031
+123,859
| +766% | +$20.3M | 0.13% | 112 |
|
|
2020
Q1 | $2.38M | Sell |
16,172
-342
| -2% | -$54.5K | 0.01% | 384 |
|
|
2019
Q4 | $2.56M | Sell |
16,514
-332
| -2% | -$47.9K | 0.01% | 433 |
|
|
2019
Q3 | $2.28M | Buy |
16,846
+61
| +0.4% | +$7.99K | 0.01% | 447 |
|
|
2019
Q2 | $2.05M | Hold |
16,785
| – | – | 0.01% | 464 |
|
|
2019
Q1 | $1.75M | Buy |
16,785
+150
| +0.9% | +$15.5K | 0.01% | 490 |
|
|
2018
Q4 | $1.89M | Hold |
16,635
| – | – | 0.01% | 459 |
|
|
2018
Q3 | $1.92M | Hold |
16,635
| – | – | 0.01% | 510 |
|
|
2018
Q2 | $1.72M | Sell |
16,635
-354
| -2% | -$35.8K | 0.01% | 540 |
|
|
2018
Q1 | $1.67M | Hold |
16,989
| – | – | 0.01% | 536 |
|
|
2017
Q4 | $1.44M | Hold |
16,989
| – | – | 0.01% | 588 |
|
|
2017
Q3 | $1.31M | Buy |
16,989
+5,050
| +42% | +$386K | 0.01% | 568 |
|
|
2017
Q2 | $930K | Buy |
+11,939
| New | +$854K | 0.01% | 478 |
|
|
2015
Q1 | – | Sell |
-12,553
| Closed | -$703K | – | 632 |
|
|
2014
Q4 | $703K | Hold |
12,553
| – | – | 0.01% | 508 |
|
|
2014
Q3 | $618K | Sell |
12,553
-500
| -4% | -$25.5K | ﹤0.01% | 511 |
|
|
2014
Q2 | $661K | Sell |
13,053
-135
| -1% | -$6.69K | 0.01% | 495 |
|
|
2014
Q1 | $598K | Buy |
+13,188
| New | +$592K | 0.01% | 500 |
|
Other funds holding RMD
CIBC Private Wealth Group's RMD Position: Q4 2025 in Review
CIBC Private Wealth Group reduced its ResMed (RMD) stake by 6.3% in Q4 2025, selling an estimated $231K and leaving 13,368 shares worth $3.22M. The position accounts for 0.01% of the portfolio, ranked #495.
CIBC Private Wealth Group first reported a position in RMD in Q1 2014 and has held it in 39 quarters since. The position peaked at $51.2M in Q2 2023. 946 funds tracked by Wall St. Rank hold RMD as of Q4 2025.
- CIBC Private Wealth Group held 13,368 shares of ResMed worth $3.22M as of Q4 2025.
- CIBC Private Wealth Group sold 903 ResMed shares in Q4 2025, an estimated $231K.
- ResMed made up 0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #495 holding.
- CIBC Private Wealth Group first reported a position in ResMed in Q1 2014 and has held it in 39 quarters since.
- CIBC Private Wealth Group's ResMed position peaked at $51.2M in Q2 2023.
- 946 funds tracked by Wall St. Rank held ResMed as of Q4 2025.
Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.